Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents

Timo Vesikari; Samantha Munson; Robert E. O'Neill; Laura J. York; John L. Perez; Lars Ostergaard; Johannes Beeslaar; Judith Absalon; Joseph J. Eiden; Kathrin U. Jansen; Thomas R. Jones; Shannon L. Harris; Roger Maansson

doi:10.1016/j.vaccine.2018.11.073

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents

Timo Vesikari
, Samantha Munson
, Robert E. O'Neill
, Laura J. York
, John L. Perez
, Lars Ostergaard
, Johannes Beeslaar
, Judith Absalon
, Joseph J. Eiden
, Kathrin U. Jansen
, Thomas R. Jones
, Shannon L. Harris
, Roger Maansson

Research output: Contribution to journal › Article › Scientific › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	1710-1719
Journal	VACCINE
Volume	37
Issue number	12
DOIs	https://doi.org/10.1016/j.vaccine.2018.11.073
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Keywords

Adolescents
Booster
Meningococcal disease
Persistence
Serogroup B
Vaccine

Publication forum classification

Publication forum level 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2018.11.073

Cite this

Vesikari, T., Munson, S., O'Neill, R. E., York, L. J., Perez, J. L., Ostergaard, L., Beeslaar, J., Absalon, J., Eiden, J. J., Jansen, K. U., Jones, T. R., Harris, S. L., & Maansson, R. (2019). Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents. VACCINE, 37(12), 1710-1719. https://doi.org/10.1016/j.vaccine.2018.11.073

@article{b0fd4a9d0d1945558910f93bd68005e6,

title = "Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents",

keywords = "Adolescents, Booster, Meningococcal disease, Persistence, Serogroup B, Vaccine, Adolescents, Booster, Meningococcal disease, Persistence, Serogroup B, Vaccine",

author = "Timo Vesikari and Samantha Munson and O'Neill, \{Robert E.\} and York, \{Laura J.\} and Perez, \{John L.\} and Lars Ostergaard and Johannes Beeslaar and Judith Absalon and Eiden, \{Joseph J.\} and Jansen, \{Kathrin U.\} and Jones, \{Thomas R.\} and Harris, \{Shannon L.\} and Roger Maansson",

year = "2019",

doi = "10.1016/j.vaccine.2018.11.073",

language = "English",

volume = "37",

pages = "1710--1719",

journal = "VACCINE",

issn = "0264-410X",

publisher = "Elsevier",

number = "12",

}

Vesikari, T, Munson, S, O'Neill, RE, York, LJ, Perez, JL, Ostergaard, L, Beeslaar, J, Absalon, J, Eiden, JJ, Jansen, KU, Jones, TR, Harris, SL & Maansson, R 2019, 'Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents', VACCINE, vol. 37, no. 12, pp. 1710-1719. https://doi.org/10.1016/j.vaccine.2018.11.073

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents. / Vesikari, Timo; Munson, Samantha; O'Neill, Robert E. et al.
In: VACCINE, Vol. 37, No. 12, 2019, p. 1710-1719.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension I Cheek for updates study in adolescents

AU - Vesikari, Timo

AU - Munson, Samantha

AU - O'Neill, Robert E.

AU - York, Laura J.

AU - Perez, John L.

AU - Ostergaard, Lars

AU - Beeslaar, Johannes

AU - Absalon, Judith

AU - Eiden, Joseph J.

AU - Jansen, Kathrin U.

AU - Jones, Thomas R.

AU - Harris, Shannon L.

AU - Maansson, Roger

PY - 2019

Y1 - 2019

KW - Adolescents

KW - Booster

KW - Meningococcal disease

KW - Persistence

KW - Serogroup B

KW - Vaccine

KW - Adolescents

KW - Booster

KW - Meningococcal disease

KW - Persistence

KW - Serogroup B

KW - Vaccine

U2 - 10.1016/j.vaccine.2018.11.073

DO - 10.1016/j.vaccine.2018.11.073

M3 - Article

SN - 0264-410X

VL - 37

SP - 1710

EP - 1719

JO - VACCINE

JF - VACCINE

IS - 12

ER -